Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen
Clinical trial NCT01985334 · COMPLETED
Trial details
- NCT number
- NCT01985334
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-14
- Primary completion
- 2016-04-29
- Enrollment
- 4389
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.